One-Page Truth-Telling Aid for Cancer Disclosure

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorChang Gung University

About this trial

The goal of this clinical trial is to learn whether a one-page communication aid can improve communication between physicians and patients with cancer during cancer-related truth-telling consultations. The one-page aid is designed to help physicians quickly understand patients' preferences and needs before the consultation.

The main questions it aims to answer are:

* Does the one-page communication aid improve patients' satisfaction with how cancer-related information is explained? * Does the one-page communication aid reduce patients' emotional distress after the consultation? * Does the one-page communication aid improve physicians' confidence in communicating cancer-related information?

Researchers will compare patients whose physicians receive the one-page communication aid with patients whose physicians provide usual care with a blank sheet for patients to write down questions. This comparison will help determine whether the one-page aid improves communication, emotional outcomes, and physician confidence.

Participants will:

* Complete questionnaires before and after the consultation * Receive either the one-page communication aid or a blank sheet, depending on their physician's group * Complete follow-up questionnaires at 3 months and 6 months after the consultation

Physicians will also complete brief questionnaires about their communication confidence at baseline, 1 week after recruitment of their first enrolled patient, 3 months, and 6 months.

Eligibility criteria

Qualifiers

Physicians who provide clinical care for patients with cancer in participating outpatient departments.

Physicians who are involved in cancer-related truth-telling or disclosure consultations.

Physicians who are willing to participate and provide informed consent.

Disqualifiers

Physicians who are unable or unwilling to complete study procedures or follow-up assessments.

Patients diagnosed with cancer.

Patients who are scheduled to receive cancer-related information from a participating physician, including information about diagnosis, recurrence, metastasis, end-of-life status.

Patients who are able to communicate in Mandarin Chinese or Taiwanese.

Trial design

Treatments tested in this trial

  • One-Page Truth-Telling Aid
  • Blank Sheet

Treatment groups

400 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Chang Gung University

Lead sponsor

Chang Gung Memorial Hospital

Collaborator